Barclays analyst Raimo Lenschow upgrades UiPath (NYSE:PATH) from Equal-Weight to Overweight.
Clene’s Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
Clene Inc (NASDAQ: CLNN)
Barclays Upgrades UiPath to Overweight
Barclays analyst Raimo Lenschow upgrades UiPath (NYSE:PATH) from Equal-Weight to Overweight.
Related Posts
B&G Foods Q2 Adj. EPS $0.41 Misses $0.49 Estimate, Sales $464.40M Beat $444.50M Estimate
B&G Foods (NYSE:BGS) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.49 by 16.33 percent. This is a 42.25 percent decrease over earnings of $0.71 per share from the same
MTBC Q4 EPS $0.34 Beats $(0.17) Estimate, Sales $37.46M Beat $37.13M Estimate
MTBC (NASDAQ:MTBC) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $(0.17) by 300 percent. This is a 8.11 percent decrease over earnings of $0.37 per share from the same period
58 Biggest Movers From Friday
Gainers
Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62.
TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30.